1st October 2024, London  – Genpax, a leader in pathogen genomics, is proud to announce a strategic partnership with IQVIA, a global provider of advanced health analytics, technology solutions, and clinical research services. Together, the two organizations aim to accelerate the fight against antimicrobial resistance (AMR) and other infectious diseases by leveraging cutting-edge genomics and data analytics solutions. Through this collaboration, Genpax will provide cutting-edg

Genpax, a life science startup focused on transforming healthcare in detecting, tracing, and mitigating the spread of bacterial pathogens, has been announced as a winner by the IET for their 2023 Excellence and Innovation Awards. The Awards celebrate the most pioneering engineering and technology innovations across 16 sectors, from energy and sustainability to manufacturing and healthcare. Chosen by a panel of expert judges, Genpax won the Health Technology award for their re

NEW YORK – Bioinformatics company Genpax estimates that healthcare systems can save considerable money while preventing infection outbreaks through microbial whole-genome sequencing. In a study published earlier this month in Microbial Genetics, the London-based company calculated that implementing a WGS surveillance strategy could prevent some 74,000 infections annually in England, saving the National Health Service approximately £480 million ($604.5 million) per year, amoun

A recent economic modelling paper by Genpax, published in Microbial Genomics, concludes that in England, the National Health Service (NHS) could save close to £0.5bn and prevent 1200 avoidable deaths, and the US health system over $3bn and 4,800 deaths by implementing whole genome sequencing (WGS) as a tool to control bacterial healthcare-associated infections. Healthcare-associated infections (HAIs) are a huge economic burden to global healthcare systems. They currently cos